array comparative genomic hybridisation von sills eric (5 Ergebnisse)

Taschenbuch. Zustand: Neu. Array Comparative Genomic Hybridisation, IVF, and Public Policy | Providing Subsidised Fertility Care in California by Integrating aCGH, IVF, and Mandatory Single Embryo Transfer | Eric Scott Sills | Taschenbuch | 60 S. | Englisch | 2013 | LAP LAMBERT Academic Publishing | EAN 9783659107054 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Essential reading for physicians, legislators, economists, ethicists, and anyone interested in reproductive health policy, this is the first economic & demographic analysis to articulate why molecular genetic techniques must be integrated with IVF going forward. The consequences of multiple embryo transfers with conventional IVF are presented with an emphasis on the economic impact of these 'super-utiliser' outcomes. Dr. Sills depicts embryo selection in traditional IVF as an incomplete procedure, and forecasts the recovery of California health spend in the context of comprehensive (embryo) chromosomal screening using array comparative genomic hybridization (aCGH) and single embryo transfer. A funding formula is developed to show how partial government support for every IVF cycle in California can still be net revenue positive for the state--because although IVF+aCGH is expensive, the price to obtain this technology is always less than the cost for one high-risk preterm/multiple birth. Dr. Sills reinforces the compelling primary interest in lowering the preterm delivery rate from IVF, yet improved access to IVF is also framed as a major secondary public health benefit. 60 pp. Englisch.

Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Sills Eric ScottE. Scott Sills (AB, Vanderbilt MD, Tennessee PhD, Westminster-London) completed his reproductive endocrinology fellowship at Cornell Univ in New York City. His research interests include molecular genetics, bioethic.

Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Essential reading for physicians, legislators, economists, ethicists, and anyone interested in reproductive health policy, this is the first economic & demographic analysis to articulate why molecular genetic techniques must be integrated with IVF going forward. The consequences of multiple embryo transfers with conventional IVF are presented with an emphasis on the economic impact of these 'super-utiliser' outcomes. Dr. Sills depicts embryo selection in traditional IVF as an incomplete procedure, and forecasts the recovery of California health spend in the context of comprehensive (embryo) chromosomal screening using array comparative genomic hybridization (aCGH) and single embryo transfer. A funding formula is developed to show how partial government support for every IVF cycle in California can still be net revenue positive for the state--because although IVF+aCGH is expensive, the price to obtain this technology is always less than the cost for one high-risk preterm/multiple birth. Dr. Sills reinforces the compelling primary interest in lowering the preterm delivery rate from IVF, yet improved access to IVF is also framed as a major secondary public health benefit.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 60 pp. Englisch.

Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Essential reading for physicians, legislators, economists, ethicists, and anyone interested in reproductive health policy, this is the first economic & demographic analysis to articulate why molecular genetic techniques must be integrated with IVF going forward. The consequences of multiple embryo transfers with conventional IVF are presented with an emphasis on the economic impact of these 'super-utiliser' outcomes. Dr. Sills depicts embryo selection in traditional IVF as an incomplete procedure, and forecasts the recovery of California health spend in the context of comprehensive (embryo) chromosomal screening using array comparative genomic hybridization (aCGH) and single embryo transfer. A funding formula is developed to show how partial government support for every IVF cycle in California can still be net revenue positive for the state--because although IVF+aCGH is expensive, the price to obtain this technology is always less than the cost for one high-risk preterm/multiple birth. Dr. Sills reinforces the compelling primary interest in lowering the preterm delivery rate from IVF, yet improved access to IVF is also framed as a major secondary public health benefit.